The Cancer Letter

Inside information on cancer research and drug development

Vol.
26
No.
26
June 30, 2000Jun 30, 2000
Free
DOWNLOAD THE PDF

Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?

Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.

North General, MSK, Form Cancer Prevention Center.

Human Genome Consortium Completes “Working Draft”.

NCI Plans $40M In Grants For Cancer Outcomes Studies.

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.

Sustained-Release Leuprolide Under Study In Phase III Trial.

Celgene Signs CRADA With NCI For Development Of CDC-501.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account